Logotype for ATS Corporation

ATS (ATS) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ATS Corporation

Q4 2025 earnings summary

9 Jul, 2026

Executive summary

  • Fourth quarter bookings reached CAD 863 million, up 9% year-over-year, with full-year bookings at a record CAD 3.3 billion, driven by diversified growth and acquisitions.

  • Adjusted Q4 revenues were CAD 721 million, down 9% year-over-year, mainly due to lower EV revenues.

  • A negotiated settlement with an EV customer resulted in a CAD 194 million inflow, reducing net debt and providing financial flexibility, but also led to a significant one-time charge and net loss for the year.

  • Life sciences, energy, and consumer products segments showed strong backlogs and opportunity funnels, while transportation remained challenged but is expected to improve.

  • Recent acquisitions (Paxiom and Heidolph) contributed to growth in life sciences and food & beverage segments.

Financial highlights

  • Q4 adjusted revenues: CAD 721 million (down 8.9% year-over-year); Q4 adjusted earnings from operations: CAD 74.3 million (down 23% year-over-year); Q4 adjusted EBITDA: CAD 97.1 million (down 16.1% year-over-year).

  • Q4 adjusted EPS: $0.41, down from $0.65 last year; Q4 net loss: $(68.9) million versus net income of $48.5 million in Q4 F2024.

  • Fiscal 2025 adjusted revenues: $2,680.2 million, down from $3,032.9 million last year; adjusted EBITDA margin for the year was 13.8%.

  • Free cash flow for fiscal 2025 was negative $52.3 million, but Q4 free cash flow improved to $10.3 million from $(16.3) million year-over-year.

  • Net debt to pro forma adjusted EBITDA: 3.9x, expected to decrease after EV settlement.

Outlook and guidance

  • Fiscal 2026 Q1 revenue expected between CAD 680 million and CAD 730 million, supported by a robust order backlog.

  • Order backlog at quarter-end: CAD 2.1 billion, highest in eight quarters, supporting revenue visibility.

  • Book-to-bill ratio at 1.23, above 1 in all market verticals, indicating strong demand.

  • Margin expansion expected as transportation recovers and life sciences bookings convert to revenue, though inflation and supply chain volatility may impact short-term results.

  • Effective tax rate expected in the mid-20% range going forward.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from ATS